INS and diabetes mellitus: Lenzen reported that alloxan inhibits glucose release induced by insulin by specifically inhibiting glucokinase activity and triggers an insulin-dependent diabetes condition by stimulating the generation of ROS through a cyclic reaction with its reduction product, dialuric acid13.